Market Size of 3D Medical and Surgical Imaging Platform Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 18.00 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | High |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
3D Medical and Surgical Imaging Platform Market Analysis
The 3D Medical and Surgical Imaging Platform Market is expected to register a CAGR of 18% over the forecast period. Certain factors, such as the various inventive resolutions from platform providers in the market and investments in healthcare IT, are also liable for driving the 3D medical and surgical imaging platform market.
- There is an increased demand for 3D medical imaging due to its vast applications in cardiology and oncology. For instance, Heart valve replacement is one of the most common procedures in cardiology. Transcatheter aortic valve replacement is considered one minimally invasive heart valve replacement procedure. Positioning the new heart valve is a severe concern to surgeons. Surgeons prefer 3D angiography imaging software to view the anatomy during the placement of heart valves, as positioning a new heart valve seems crucial.
- Additionally, in May 2021, the National Health Service England (NHS) unveiled a unique technology called HeartFlow to detect and treat people with suspected heart disease quickly. Delivered under the NHS Long Term Plan, HeartFlow is claimed to convert a regular computed tomography (CT) scan of the heart into a three-dimensional (3D) image to enable the detection of coronary heart disease in 20 minutes, further driving the market growth.
- Due to the surging development of modern visualization methods and technology platforms, along with rising demand for 3D imaging in diagnosing and monitoring chronic diseases, the market is growing. A shift toward minimally invasive procedures and increasing adoption of hybrid operating rooms also provide traction for the market.
- Furthermore, in December 2021, WEHI (Walter and Eliza Hall Institute of Medical Research) researchers developed enhanced 3D imaging technology to model how breast cancer cells invade and spread into the bone and remodify themselves to fuel tumor growth. The research could guide the development of new therapies for patients suffering from cancers that are typically applied to the bone, including breast and prostate cancers.
- The rapid advancements in innovative imagining techniques are paving the way for the growth of the studied market. For instance, in February 2021, a research team led by UMass Lowell introduced a new 3D imaging technique to detect breast cancer and other diseases, including COVID-19. The noninvasive medical technology employs specialized contrasting dye that identifies breast cancer cells, allowing practitioners to visualize human tissue inside the body better. The dye amplifies the X-ray signal in tumors when combined with computed tomography (CT) scanner, called a "photon-counting spectral CT," which produces multi-colored, 3D images. The researchers claimed that the contrast agents, combined with spectral CT and machine learning, could lead to a more precise disease diagnosis and significantly assist in early intervention.
- Furthermore, the COVID-19 pandemic contributed to a 16% increase in the estimated number of deaths in OECD nations in 2020 and the first half of 2021, both directly and indirectly. Life expectancy has decreased in 24 of the 30 countries, and the pandemic has had a significant mental health impact. In addition, the pandemic has resulted in a substantial surge in healthcare spending across the OECD.
3D Medical and Surgical Imaging Platform Industry Segmentation
3D medical imaging It's a method of obtaining a 3D volumetric image of multiple 2D images that are computer reconstructed using a mathematical "back-projection" operation to retrieve pixel data from projected image signals passing through a patient and detected by multichannel detector arrays all around the patient. Surgical imaging platforms allow physicians and surgeons to see internal images of the body, including organs and bones, prior to and during surgical procedures. These images aid reduce risk and speeding recovery. The studied market is segmented by Deployment such as On-premise, Cloud among various components, including hardware, software, and services in different Applications such as CT-Scan, MRI, Ultrasound, Neurological Imaging, and Spinal Imaging among multiple geographies.
By Deployment | |
On-premise | |
Cloud |
By Component | |
Hardware | |
Software & Solution |
By Application | |
CT-Scan | |
MRI | |
Ultrasound | |
Neurological Imaging | |
Spinal Imaging | |
Other Applications |
By Geography | |
North America | |
Europe | |
Asia Pacific | |
Latin America | |
Middle East & Africa |
3D Medical and Surgical Imaging Platform Market Size Summary
The 3D medical and surgical imaging platform market is experiencing significant growth, driven by advancements in healthcare IT and innovative solutions from platform providers. The increasing demand for 3D imaging in cardiology and oncology, particularly for procedures like heart valve replacements, is a key factor propelling market expansion. The adoption of technologies such as HeartFlow by the NHS and the development of enhanced imaging techniques by research institutions like WEHI are further contributing to market growth. The shift towards minimally invasive procedures and the rising use of hybrid operating rooms are also providing momentum to the market. Additionally, the COVID-19 pandemic has led to increased healthcare spending, which has indirectly boosted the demand for advanced imaging solutions.
Cloud computing is playing a pivotal role in the market's evolution, offering competitive advantages in data management and facilitating the transition to cloud-based enterprise imaging systems. These systems provide seamless integration with electronic medical records and reduce IT infrastructure costs, allowing healthcare providers to focus more on patient care. North America is expected to maintain a significant market share due to its well-established healthcare infrastructure, increasing prevalence of chronic diseases, and the adoption of automated 3D imaging scanners. The market is characterized by consolidation, with major players investing in R&D to develop advanced products and expand their portfolios through mergers, acquisitions, and partnerships.
3D Medical and Surgical Imaging Platform Market Size - Table of Contents
-
1. MARKET INSIGHTS
-
1.1 Market Overview
-
1.2 Industry Attractiveness - Porters Five Forces Analysis
-
1.2.1 Bargaining Power of Suppliers
-
1.2.2 Bargaining Power of Buyers
-
1.2.3 Threat of New Entrants
-
1.2.4 Threat of Substitutes
-
1.2.5 Intensity of Competitive Rivalry
-
-
1.3 Industry Value Chain Analysis
-
1.4 Assessment of Impact of COVID-19 on the Market
-
-
2. MARKET SEGMENTATION
-
2.1 By Deployment
-
2.1.1 On-premise
-
2.1.2 Cloud
-
-
2.2 By Component
-
2.2.1 Hardware
-
2.2.2 Software & Solution
-
-
2.3 By Application
-
2.3.1 CT-Scan
-
2.3.2 MRI
-
2.3.3 Ultrasound
-
2.3.4 Neurological Imaging
-
2.3.5 Spinal Imaging
-
2.3.6 Other Applications
-
-
2.4 By Geography
-
2.4.1 North America
-
2.4.2 Europe
-
2.4.3 Asia Pacific
-
2.4.4 Latin America
-
2.4.5 Middle East & Africa
-
-
3D Medical and Surgical Imaging Platform Market Size FAQs
What is the current 3D Medical and Surgical Imaging Platform Market size?
The 3D Medical and Surgical Imaging Platform Market is projected to register a CAGR of 18% during the forecast period (2024-2029)
Who are the key players in 3D Medical and Surgical Imaging Platform Market?
Ambra Health Inc., Arterys Inc., Brainlab AG, Depuy Synthes Inc. and Medtronic Inc. are the major companies operating in the 3D Medical and Surgical Imaging Platform Market.